RAFAEL HOLDINGS, INC. Repayments of Related Party Debt
RAFAEL HOLDINGS, INC. (RFL) reported Repayments of Related Party Debt of $1.70 million for the 12-month period ending 2018-07-31, per its 10-K filed 2019-10-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2019-10-04
- RAFAEL HOLDINGS, INC. repayments of related party debt for the quarter ending 2018-07-31 was $815.00K.
- RAFAEL HOLDINGS, INC. repayments of related party debt for the quarter ending 2018-04-30 was -$371.00K, a 103.55% decline year-over-year.
- RAFAEL HOLDINGS, INC. repayments of related party debt for the quarter ending 2017-04-30 was $10.44M.
- RAFAEL HOLDINGS, INC. repayments of related party debt for fiscal 2018 was $1.70M.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2018-07-31 | $815.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $444.00K derived: sum of 2 quarters · filed 2019-10-04 | $1.70M 10-K · filed 2019-10-04 | |
| 2018-04-30 | -$371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $885.00K 10-Q · filed 2018-06-11 | ||
| 2018-01-31 | $1.26M 10-Q · filed 2018-03-12 | |||
| 2017-04-30 | $10.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $19.77M 10-Q · filed 2018-06-11 | ||
| 2017-01-31 | $9.33M 10-Q · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |